BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/15/2015 11:01:00 AM | Browse: 1334 | Download: 2941
 |
Received |
|
2014-08-25 16:55 |
|
Peer-Review Started |
|
2014-08-26 14:24 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-10-10 13:47 |
|
Revised |
|
2014-11-19 14:43 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-12-26 13:41 |
|
Second Decision by Editor-in-Chief |
|
2014-12-27 10:14 |
|
Final Decision by Editorial Office Director |
|
2015-01-08 17:20 |
|
Articles in Press |
|
2015-01-08 17:34 |
|
Edit the Manuscript by Language Editor |
|
2015-01-22 23:11 |
|
Typeset the Manuscript |
|
2015-03-31 19:48 |
|
Publish the Manuscript Online |
|
2015-04-15 11:01 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Prospective Study |
| Article Title |
Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ya-Ping Liao, Jia-Lu Jiang, Wai-Yi Zou, Duo-Rong Xu and Juan Li |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Wai-Yi Zou, Associate Professor, Department of Hematology, the First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan 2nd Road, Yuexiu District, Guangzhou 510000, Guangdong Province, China. waiyizou@medmail.com.cn |
| Key Words |
Hematopoietic stem cell transplantation; Hepatitis B virus; Antiviral therapy; Nucleotide analogues |
| Core Tip |
The threshold of pre-transplantation hepatitis B virus (HBV) DNA for allo-HSCT was defined as 103 IU/mL. Only 1 patient developed HBV reactivation due to early discontinuation of antiviral therapy. The hepatitis B surface antigen (HBsAg)(+), HBsAg(-)/hepatitis B core antibody(+) and non-HBV infected groups showed no statistically significant differences in the incidence of graft-vs-host disease, drug-induced liver injury, hepatic veno-occlusive disease death, survival times and post-transplantation cumulative survival rates. In summary, suppression of HBV DNA to < 103 IU/mL before transplantation, continued antiviral therapy and close monitoring of immune markers of hepatitis B and HBV DNA after trans plantation may assure the safety of allogeneic hematopoietic stem cell transplantation. |
| Publish Date |
2015-04-15 11:01 |
| Citation |
Liao YP, Jiang JL, Zou WY, Xu DR, Li J. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients. World J Gastroenterol 2015; 21(14): 4284-4292 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i14/4284.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i14.4284 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
